5.41

5.41 (0.82%)

As of Feb 09, 2023

DURECT CORP [DRRX]

Source: 

Company Overview

We are a biopharmaceutical company advancing novel and potentially lifesaving investigational therapies derived from our Epigenetic Regulator Program.DUR928, a new chemical entity in clinical development, is the lead candidate in our Epigenetic Regulator Program.An endogenous, orally bioavailable small molecule, DUR-928 has been shown in preclinical studies to play an important regulatory role in lipid homeostasis, inflammation, and cell survival.

CountryUS
Headquarterscupertinocalifornia
Phone Number(408) 777-1417
Industrypharmaceutical preparations
CEOJames E. Brown
Websitewww.posimir.com